Female sex is associated with improved survival after perioperative immunotherapy in resectable non-small cell lung cancer
Vikram Krishna, Claire Perez, Kellie Knabe, Bryan Navarro, Raffaele Rocco, Andrew R. Brownlee, Clark Fuller, Harmik J. Soukiasian, Philicia Moonsamy · 2026
Read Female sex is associated with improved survival after perioperative immunotherapy in resectable non-small cell lung cancer by Vikram Krishna, Claire Perez, Kellie Knabe, Bryan Navarro, Raffaele Rocco, Andrew R. Brownlee, Clark Fuller, Harmik J. Soukiasian, Philicia Moonsamy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13358507.txt.
Description
Vikram Krishna and others found that female sex is linked to better living after perioperative immune care for resectable non-small cell lung cancer, in 2026. Sex-related immune gaps might affect immune care results, but women are underrepresented in immune care trials, leaving the question open. The team matched living by sex in a large national cohort.
National Cancer Bank records for stage IB to IIIA people who had surgery and perioperative immune care between 2004 and 2023 were studied, with overall living as the primary outcome. Women survived longer than men after adjustment. The finding highlights sex as a factor in immune care response and calls for more typical trial enrolment.
Catalog record
| CREATOR | Vikram Krishna, Claire Perez, Kellie Knabe, Bryan Navarro, Raffaele Rocco, Andrew R. Brownlee, Clark Fuller, Harmik J. Soukiasian, Philicia Moonsamy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |